Jennifer Bailey

Title: Innovations of Jennifer Bailey

Introduction

Jennifer Bailey is an accomplished inventor based in Waltham, MA (US). She has made significant contributions to the field of glycopeptides, particularly in their application to monoclonal antibodies. Her work has implications for immunology and cancer treatment.

Latest Patents

Jennifer Bailey holds a patent for "Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128." This invention relates to a glycopeptide that includes one or more modified amino acid residues with a sidechain comprising a monosaccharide or an oligosaccharide. The glycopeptide is designed to bind specifically to a carbohydrate-binding monoclonal antibody from the PGT128 family, preferably with an affinity of less than 100 nM. The patent also discloses immunogenic conjugates that include the glycopeptide, as well as pharmaceutical compositions that utilize the glycopeptide or the immunogenic conjugate. Various methods of using these glycopeptides, immunogenic conjugates, and pharmaceutical compositions are also outlined, including inducing an immune response, inhibiting viral infection, treating cancerous conditions, and detecting neutralizing antibodies.

Career Highlights

Jennifer is affiliated with Brandeis University, where she continues her research and development in the field of glycopeptides. Her innovative work has garnered attention and recognition within the scientific community.

Collaborations

Some of her notable coworkers include Isaac Jonathan Krauss and Satoru Horiya, who contribute to her research endeavors.

Conclusion

Jennifer Bailey's contributions to the field of glycopeptides and their applications in medicine highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to impact therapeutic strategies significantly.